DESTIN, Fla., July 13 /PRNewswire-FirstCall/ -- Concordis Group, Inc. (Pink Sheets: CNGI), a growing financial holding company, today announced the development of a new captive insurance cell targeting the excessive medical costs experienced by mid-market companies.

This new cell will be marketed to small-to-medium size businesses that are looking for ways to control their escalating health care costs.

Trent Sommerville, CEO of Concordis Group, Inc. stated, "Most small-to-medium size businesses today are very concerned about new government regulations regarding health care and how it affects their business.  The program's structure is designed to allow our clients to better control these costs which ultimately impact their bottom line."

This cell is expected to be launched by the 4th quarter 2010.

About Concordis Group, Inc.

Concordis Group, Inc. is a diversified holding company that provides business insurance solutions through its two wholly own subsidiaries: Concordis Insurance SPC (CISPC) and Concordis Capital, Inc.(CCI).  CISPC, a Cayman Island corporation, is a captive insurance company that specializes in structuring and managing alternative risk management solutions for mid-market companies.  CCI, a Florida corporation, provides captive cell funding for CISPC and other businesses and organizations.

Concordis Group's business strategy is based upon strong organic growth combined with strategic acquisitions of companies in the financial services and insurance industries that create additional synergy, have positive cash-flow, exhibit strong long-term growth potential, and have highly qualified management teams.

SOURCE Concordis Group, Inc.